Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.0082 | 1 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |